Source: International Congress 2018 – Biomarkers for evaluating asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Wang (Oxford, United Kingdom), J. Verbakel (Oxford, United Kingdom), A. Fleming-Nouri (Oxford, United Kingdom), J. Brewin (Oxford, United Kingdom), J. Oke (Oxford, United Kingdom), I. Pavord (Oxford, United Kingdom), M. Thomas (Southampton, United Kingdom). Prognostic value of using FeNO to guide step-down treatment decisions in asthma. 1097

Member's Comments

No comment yet.

Related content which might interest you: Predictive value of spirometry trend and FeNO for difficult to treat asthma in children Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010 FeNO testing for asthma diagnosis in primary care Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care Year: 2020 FeNO interpretation aid: A clinical decision support tool for interpretation of FeNO values in the patients with respiratory symptoms Source: Annual Congress 2011 - E-learning Year: 2011 Feasibility and acceptability of spirometry and FeNO testing in children treated for asthma in primary care Source: International Congress 2017 – Diagnostic tools in paediatric asthma Year: 2017 Prognostic indices for COPD patient management: how many do we need? Source: Eur Respir J 2011; 39: 223-224 Year: 2012 Prognostic indices for COPD patient management: how many do we need? Source: Eur Respir J 2012; 39: 223-224 Year: 2012 Optimal cut-off value and clinical usefulness of adherence starts with knowledge-12 (ASK-12) in asthmatic patients taking inhaled corticosteroid Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Measuring airway hyperresponsiveness: does it add to routine measures of clinical efficacy in guiding asthma therapy? Source: Eur Respir J 2006; 28: Suppl. 50, 319s Year: 2006 May the value of FEV1 be helpful in the choice of the antibiotic therapy in acute exacerbation of COPD? Source: Eur Respir J 2001; 18: Suppl. 33, 189s Year: 2001 A comparison between the diagnostic value of bronchodilator response in spirometry and questionnaire in determining asthma Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 The usefulness of the simultaneous measurement of IOS and FeNO in the management of asthma Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Suppression of FENO with observed inhaled corticosteroid therapy in severe asthma: is it a useful test in clinical practice? Source: ERJ Open Res, 5 (4) 00123-2019; 10.1183/23120541.00123-2019 Year: 2019 Early detection of asthma exacerbations and the use of action points for treatment decisions in self-management plans Source: Annual Congress 2011 - Monitoring exacerbations of airway diseases Year: 2011 Clinical utility of measuring FeNO to assess inhaled corticosteroid response in asthma. Source: International Congress 2017 – Airway disease and exacerbations Year: 2017 Comparison of the asthma control test and % predicted FEV1 in relation to correlation with physicians assessment of asthma control and treatment decisions Source: Annual Congress 2011 - Update on monitoring airway diseases Year: 2011 Prognostic values of biomarkers in COPD Source: Annual Congress 2013 –Natural history of COPD: novel aspects Year: 2013 Comparative assessment of asthma control test and GINA classification in predicting asthma severity Source: Annual Congress 2007 - Airway regulation, provocation and monitoring II Year: 2007 Clinical value of the immediate bronchodilator response to diagnose asthma in steroid-naïve adults Source: International Congress 2019 – Clinical implications of asthma management Year: 2019 Physician assessment of asthma control in patients receiving omalizumab in a real-world setting Source: Annual Congress 2012 - Asthma treatment: efficacy and safety Year: 2012 Cost-effectiveness of eNO measurements in chronic asthma management Source: Eur Respir J 2007; 30: Suppl. 51, 193s Year: 2007